Home › Funds › RA CAPITAL MANAGEMENT, L.P. › VOR

RA CAPITAL MANAGEMENT, L.P. position in VOR

VOR BIOPHARMA INC COM NEW · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 2,402,095 shares of VOR (VOR BIOPHARMA INC COM NEW) in its Q2 2026 13F filing — a position valued at US$44.2M, representing 0.38% of its reported portfolio and ranking #42 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed VOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.40M sh
Reported value held$44.22M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s VOR position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in VOR in Q3 2023 at 22,748,880 shares (US$48.2M). The position peaked in Q3 2025 at 1,982,301 shares, worth US$96.6M. Across 12 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 2,402,095 shares valued at US$44.2M — a reduction of -3,002,903 shares quarter over quarter.. Notable position changes include a 74% increase in Q4 2024 (shares fell 35% over the following quarter), a 95% trim in Q3 2025 (shares fell 73% over the following quarter), a 173% increase in Q4 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.75M $48.23M New
Q4 2023 22.75M $51.18M Hold
Q1 2024 22.75M $53.91M Hold
Q2 2024 22.75M $22.75M Hold
Q3 2024 22.75M $15.92M Hold
Q4 2024 39.65M $44.01M Add
Q1 2025 39.65M $28.45M Hold
Q2 2025 39.65M $64.23M Hold
Q3 2025 1.98M $96.58M Reduce
Q4 2025 5.40M $70.70M Add
Q1 2026 5.40M $96.43M Hold
Q2 2026 2.40M $44.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VOR and 13F data

VOR (VOR BIOPHARMA INC COM NEW) is a Health Care company. 75 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$104.4M), FCPM III SERVICES B.V. (US$75.8M), Venrock Adviser, LLC (US$56.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VOR

All VOR fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held VOR?

RA CAPITAL MANAGEMENT, L.P. has disclosed VOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in VOR?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 2.40M shares of VOR (VOR BIOPHARMA INC COM NEW), valued at $44.22M, representing 0.38% of its reported portfolio and ranking #42.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling VOR?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in VOR. The position peaked in Q3 2025 at 1.98M shares.

Which other funds hold VOR?

Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.